Umoja Biopharma
Umoja Biopharma develops in vivo CAR T cell therapies that generate cancer-fighting T cells directly in a patient’s body. Its therapies are designed to treat cancers while making treatment more accessible by avoiding the multi-week cell manufacturing required for ex vivo CAR T therapies.
Facts
- HQ
- Seattle, WA 98109
- Sectors
- Biotechnology Research
- Founded
- 2019
- Type
- Corporation Seattle business license
- Employees
- 254
- Registered name
- Umoja Biopharma Inc Seattle business license
- Members see funding amounts. .
Is this your organization? Claim it
Members see Umoja Biopharma's funding rounds, amounts and investors.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Andy Scharenberg Executive Officer, Director, Co-founder & Chief Executive Officer
-
Michael Jensen Co-Founder
-
Nate Hardy Executive, Chief Financial Officer